ISL
SRTS icon

Ingalls & Snyder LLC’s Sensus Healthcare SRTS Stock Holding History

Ingalls & Snyder LLC’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Hold
55,000
– – 0.01% 417
2025
Q4 		$219K Buy
+55,000
New +$204K 0.01% 430

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $86.7M AUM

Ingalls & Snyder LLC's SRTS Position: Q1 2026 in Review

Ingalls & Snyder LLC held its Sensus Healthcare (SRTS) position steady in Q1 2026 at 55,000 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #417.

Ingalls & Snyder LLC first reported a position in SRTS in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Ingalls & Snyder LLC held 55,000 shares of Sensus Healthcare worth $219K as of Q1 2026.
  • Ingalls & Snyder LLC left its Sensus Healthcare share count unchanged in Q1 2026.
  • Sensus Healthcare made up 0.01% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #417 holding.
  • Ingalls & Snyder LLC first reported a position in Sensus Healthcare in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.